The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 352:1929 May 5, 2005 Number 18
NextNext

Case 4-2005: Sodium Stibogluconate for Cutaneous Leishmaniasis

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-PDA Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited
-E-mail When Letters Appear

More Information
-Related Article
by Weller, P. F.
-PubMed Citation
To the Editor: In Case 4-2005 (Feb. 10 issue),1 a discussant states that sodium stibogluconate (Pentostam, GlaxoSmithKline, United Kingdom) is available in the United States only from the Centers for Disease Control and Prevention (CDC). The U.S. military is another potential supplier of sodium stibogluconate. This drug has been used under an investigational-new-drug protocol at Walter Reed Army Medical Center (Washington, D.C.) since 1978 and is now also available at Brooke Army Medical Center (San Antonio, Tex.). Cutaneous leishmaniasis has been diagnosed in more than 800 soldiers and civilian contractors returning from Iraq or Afghanistan.2,3 Sodium stibogluconate may be a . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.